Abstract
Background Dobutamine stress cardiac magnetic resonance imaging (DCMR) was not an established test for coronary ischemia in 2003/2004. Meanwhile, long-term outcome has demonstrated a strong prognostic value of negative DCMR testing (Kelle et al. JACC CVI 2011). However, only limited data are as yet available about reimbursement for and costeffectiveness of DCMR in patients with stable coronary artery disease (CAD).
Highlights
Dobutamine stress cardiac magnetic resonance imaging (DCMR) was not an established test for coronary ischemia in 2003/2004
An electronic patient information system (PIS) archive allowed the selection of a matched control group of patients undergoing cardiac catheterization (CA) without prior DCMR
A group of patients with DCMR guided treatment strategy (DCMR) (N= 264; CA: N=65; no CA: N=199) was matched to a control group with CA indicated by standard evaluation (SECA) (N=442)
Summary
Dobutamine stress cardiac magnetic resonance imaging (DCMR) was not an established test for coronary ischemia in 2003/2004. Long-term outcome has demonstrated a strong prognostic value of negative DCMR testing (Kelle et al JACC CVI 2011). Only limited data are as yet available about reimbursement for and costeffectiveness of DCMR in patients with stable coronary artery disease (CAD)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
